All Articles

Neonode's Q2 report shows shrinking revenue and widening losses, but a massive jump in MultiSensing® license sales points to a deliberate, high-stakes bet on the automotive sector.

Niagen Bioscience heads to a key investor conference. Can its CFO translate the complex science of healthy aging into a compelling story for market growth?

As AI-driven attacks escalate, a critical skills gap leaves firms exposed. An upcoming summit reveals the industry's plan to train a new class of defenders.

Intuit's new AI chat and enterprise tools promise a new era for CFOs. But can they overcome the hurdles of AI trust and a crowded competitive field?

A New York non-profit's monthly alert reveals the street-level tactics of a massive illicit industry. But the real story is the multi-front war being waged by regulators and citizens against a fraud enterprise that costs taxpayers billions.

A decade after its first LNG cargo, Cheniere Energy is a global titan. But as it celebrates, a closer look reveals a complex legacy of market dominance, geopolitical power, and persistent climate questions.

A new competition offers a dream career, but a look inside reveals a complex system of philanthropy, high-stakes fundraising, and questions of transparency.

Saleo's #127 Inc. 5000 rank and acquisition by Consensus isn't just a growth story. It's proof that the B2B buying experience has fundamentally changed.

Generative AI created a flood of content. Now, the real challenge is managing it. Brightspot's new Esca Automations introduces 'agentic AI' to orchestrate.

The deal is more than a regional expansion; it's a strategic play in a consolidating EHS market, highlighting the industry's race for talent and scale.

With a top-tier sponsorship, DiamondLake signals its arrival in institutional blockchain. But do its financials and unfinalized deals support the hype?

eClerx brings back early leader Hoshi Mistry to steer its Customer Experience unit, signaling a strategic push to fuse institutional knowledge with AI innovation.

Karma Automotive unveils an ambitious trio of vehicles, blending hybrid power with a pioneering leap into solid-state batteries to redefine American luxury.

Amprion's expansion of its alpha-synuclein test to Europe isn't just a deal; it's the build-out of a new infrastructure for understanding the brain.

On World Elephant Day, a campaign to free an elephant named Joyce from Six Flags ignites a fierce debate on ethics, activism, and corporate responsibility.

With a cash runway into 2029, Avalyn Pharma is advancing a novel inhaled drug platform, hitting key clinical milestones to challenge an oral-dominated market.

Haoxi Health announces a second reverse split in three months, a move to save its Nasdaq listing that investors see as a red flag, despite its strategic AI push.

A major alliance of urban schools is reframing the lunch line as the front line of preventive healthcare, appointing a doctor to tackle childhood disease.

Clearwave's new 'agentic workforce' automates the entire patient journey. It promises massive efficiency gains, but what is the human cost and benefit?

Turnout's new AI platform, fronted by Steve Harvey, aims to unlock $140B in government benefits. Is this a tech-for-good revolution or a savvy business play?